Glucosides of Chaenomeles speciosa remit rat adjuvant arthritis by inhibiting synoviocyte activities

Acta Pharmacologica Sinica

Volumn 24, Issue 11, 2003, Pages 1161-1166+1176

  Dai, Min ^b   Wei, Wei ^a   Shen, Yu Xian ^a   Zheng, Yong Qiu ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b ANHUI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Chaenomeles speciosa; Experimental arthritis; Glucosides; Immunologic adjuvants; Interleukin 1; Prostaglandins E; Synovial membrane; Tumor necrosis factor

Indexed keywords

ACTARIT; CHAENOMELES SPECIOSA EXTRACT; COLLAGENASE; FREUND ADJUVANT; GLUCOSIDE; INTERLEUKIN 1; PLANT EXTRACT; PROSTAGLANDIN E2; TRYPSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ANIMAL CELL; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVITY; CELL ASSAY; CELL ULTRASTRUCTURE; CHAENOMELES SPECIOSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEVICE; DRUG EFFECT; MALE; MEDICINAL PLANT; NONHUMAN; PAIN; PAW EDEMA; POLYARTHRITIS; POLYARTHRITIS INDEX; PROSTAGLANDIN SYNTHESIS; RADIOIMMUNOASSAY; RAT; SYNOVIOCYTE; THYMOCYTE PROLIFERATION ASSAY; TRANSMISSION ELECTRON MICROSCOPY; VOLUMETER; VOLUMETRY;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CELLS, CULTURED; DINOPROSTONE; DRUGS, CHINESE HERBAL; FRUIT; GLUCOSIDES; INTERLEUKIN-1; MALE; MICE; MICE, INBRED C57BL; PAIN THRESHOLD; PLANTS, MEDICINAL; RATS; RATS, SPRAGUE-DAWLEY; ROSACEAE; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0242473874     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Jacobson PB, Borgan SJ, Wiliox DM. A new Spin an old model in vivo evaluation of disease progress by magnetic response imaging with respect to standard inflammatory parameters and his pathology in adjuvant arthritis rat. Arthritis Rheum 1999; 42: 2060-73.
2. Wei W, Chen MZ, Xu SY. Pharmacological effects of isoxicam. Chin Pharmacol Bull 1986; 2: 29-34.
3. Gu WZ, Sydney R. Brandwein. Inhibition of type II collagen-induced arthritis in rats by triptolide. Int J Immunopharmacol 1998; 20: 389-400.
4. Pezet S, Onteniente B, Jullien J, Junier MP, Grannec G, Rudkin BB, et al. Differential regulation of NGF receptors in primary sensory neurons by adjuvant-induced arthritis in the rat. Pain 2001; 10: 113-25.
5. Hui A, Kulkarni GV, Hunter WL, McCulloch CA, Cruz TF. Paclitaxel selectively induces mitotic arrest and apoptosis in proliferating bovine synoviocytes. Arthritis Rheum 1997; 40: 1073-84.
6. Vandberg WB, Joosten LA, Vandeloo FA. TNF alpha and IL-1 beta are separate targets in chronic arthritis. Clin Exp Rheum 1999; 17: 105-14.
7. Li WG, Zhang XY, Wu YJ, Tian X. Anti-inflammatory effect and mechanism of proanthocyanidins from grape seeds. Acta Pharmacol Sin 2001; 22: 1117-20.
8. Taylor PC. Anti-tumor necrosis factor therapies. Curr Opin Rheum 2001; 13: 164-9.
9. Dager JM, Feigell, Edwards CK, Burger D. Antiinterleukin-1 therapy in rheumatic disease. Curr Opin Rheum 2001; 13: 170-6.
10. Bergmsn P, Schoutens A. Prostaglandins and bone. Bone 1995; 16: 485-8.
11. Ben-Av P, Croford LJ, Wilder RL, Hla T. Induction of vascular endthelial growth factor expression in synovial fibroblasts by prostaglandin E and IL-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett 1995; 372: 83-7.
12. Amano S, Naganuma K, Kawata Y, Kawakami K, Kitano S, Hanzawa S. Prostaglandin E2 stimulates osteoclast formation via endogenous IL-1β expressed through protein kinase A. J Immunol 1996; 156: 1931-6.
13. Mauveal A, Halcin C, Vasiloudes P, Parks WC, Kurkinen M, Uitto J. Uncoordinate regulation of collagenase, stromelysin, and tissue inhibitor of metalloproteinases genes by prostaglanding E2: selective enhancement of collagenase gene expression in human dermal fibroblasts in culture. J Cell Biochem 1994; 54: 465-72.